Viking Global Investors LP Bridge Bio Pharma, Inc. Transaction History
Viking Global Investors LP
- $29.6 Billion
- Q4 2024
A detailed history of Viking Global Investors LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Viking Global Investors LP holds 25,120,991 shares of BBIO stock, worth $851 Million. This represents 2.33% of its overall portfolio holdings.
Number of Shares
25,120,991
Previous 25,120,991
-0.0%
Holding current value
$851 Million
Previous $640 Million
7.78%
% of portfolio
2.33%
Previous 2.47%
Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
318Shares Held
177MCall Options Held
13MPut Options Held
2.48M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$856 Million44.98% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$511 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$422 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$209 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$206 Million61.0% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.02B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...